These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15745089

  • 21. [The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma].
    Ishizuka H, Arakawa Y, Nakano E.
    Rinsho Byori; 1992 Dec; 40(12):1265-73. PubMed ID: 1284914
    [Abstract] [Full Text] [Related]

  • 22. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS, Duseja A, Rajwanshi A, Gupta SK, Sehgal S, Suri S, Chawla Y.
    Trop Gastroenterol; 2004 Dec; 25(3):116-20. PubMed ID: 15682657
    [Abstract] [Full Text] [Related]

  • 23. Hepatocellular carcinoma presenting as spinal cord compression in Native Americans with controlled hepatitis C: two case reports.
    Liaukovich M, Wu S, Yoon S, Schaffer J, Wang JC.
    J Med Case Rep; 2018 Sep 30; 12(1):282. PubMed ID: 30268151
    [Abstract] [Full Text] [Related]

  • 24. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F, Benevegnù L, Drago C, Casarin C, Cechetto A, Realdi G, Ruol A.
    Hepatogastroenterology; 1989 Dec 30; 36(6):519-21. PubMed ID: 2482242
    [Abstract] [Full Text] [Related]

  • 25. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU.
    World J Gastroenterol; 2016 Sep 14; 22(34):7806-12. PubMed ID: 27678364
    [Abstract] [Full Text] [Related]

  • 26. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
    Lee HY, Jung JH, Kang YS, Kim YS, Moon HS, Park KO, Lee YS, Kim SM, Seo SW, Lee SW, Kim SH, Lee BS, Kim NJ.
    Korean J Gastroenterol; 2004 Apr 14; 43(4):252-9. PubMed ID: 15100489
    [Abstract] [Full Text] [Related]

  • 27. Hepatocellular carcinoma presenting as nervous system involvement.
    Chen SF, Tsai NW, Lui CC, Lu CH, Huang CR, Chuang YC, Cheng YF, Kuo CH, Chang WN.
    Eur J Neurol; 2007 Apr 14; 14(4):408-12. PubMed ID: 17388989
    [Abstract] [Full Text] [Related]

  • 28. Analysis of Lamin B1, Vimentin and Anti-Ku86 as Prospective Biomarkers of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection.
    Idriss NK, Fakhry M, Imam HM, Abd-Elmoez FA, Abdelewahab H, Abdel-Wahid L, Abbas WA, Abozaid MAA, Sayed Z, Ashmawy AM.
    Cell Physiol Biochem; 2019 Apr 14; 52(3):595-605. PubMed ID: 30897324
    [Abstract] [Full Text] [Related]

  • 29. A case of hepatocellular carcinoma who admitted with Raynaud's phenomenon.
    Sahan C, Ucer T, Aksakal E.
    Rheumatol Int; 2006 Nov 14; 27(1):87-9. PubMed ID: 16816957
    [Abstract] [Full Text] [Related]

  • 30. Fine needle aspiration biopsy of hepatocellular carcinoma. Diagnostic dilemma at the ends of the spectrum.
    Wee A, Nilsson B, Tan LK, Yap I.
    Acta Cytol; 1994 Nov 14; 38(3):347-54. PubMed ID: 7514830
    [Abstract] [Full Text] [Related]

  • 31. [A hepatocellular carcinoma revealed by paraplegia caused by a vertebral metastasis].
    Omura K, Kawaura Y, Murakami N, Morita K, Iwa T, Sasaki S.
    Gan No Rinsho; 1989 Oct 14; 35(12):1448-52. PubMed ID: 2554010
    [Abstract] [Full Text] [Related]

  • 32. Consequences of missed opportunities.
    Dombrowski JC, Kao H, Renda N, Kohlwes RJ.
    J Hosp Med; 2007 Jul 14; 2(4):274-9. PubMed ID: 17705210
    [No Abstract] [Full Text] [Related]

  • 33. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F.
    Am J Gastroenterol; 2006 Mar 14; 101(3):524-32. PubMed ID: 16542289
    [Abstract] [Full Text] [Related]

  • 34. Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
    Entezami M, Becker R, Ebert A, Pritze W, Weitzel H.
    Gynecol Oncol; 1996 Sep 14; 62(3):405-7. PubMed ID: 8812541
    [Abstract] [Full Text] [Related]

  • 35. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.
    Anticancer Res; 2013 Mar 14; 33(3):1013-21. PubMed ID: 23482775
    [Abstract] [Full Text] [Related]

  • 36. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
    Kang SH, Kim DY, Jeon SM, Ahn SH, Park JY, Kim SU, Kim JK, Lee KS, Chon CY, Han KH.
    Eur J Gastroenterol Hepatol; 2012 Jul 14; 24(7):849-56. PubMed ID: 22495400
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Jul 14; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 38. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
    Cheema AW, Hirschtritt T, Van Thiel DH.
    Hepatogastroenterology; 2004 Jul 14; 51(60):1676-8. PubMed ID: 15532803
    [Abstract] [Full Text] [Related]

  • 39. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 14; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 40. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct 14; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.